Please enable JavaScript to continue using this application.

Compare $ACAD vs $LEGN | Chartloom

Compare

$ACAD vs $LEGN

ACADIA Pharmaceuticals Inc · Legend Biotech Corp

ACAD

ACADIA Pharmaceuticals Inc

LEGN

Legend Biotech Corp

Compare $ACAD vs $LEGN

Comparing ACADIA Pharmaceuticals Inc and Legend Biotech Corp

ACADACADIA Pharmaceuticals Inc

LEGNLegend Biotech Corp

ACADACADIA Pharmaceuticals Inc

Market cap

$3.39B

P/E (TTM)

8.99x

Forward P/E (NTM)

23.42x

Forward P/S (NTM)

2.37x

Rev growth (TTM)

48.3%

YTD performance

-24.8%

52W performance

-7.2%

FCF yield

4.3%

LEGNLegend Biotech Corp

Market cap

$3.62B

P/E (TTM)

—

Forward P/E (NTM)

25.42x

Forward P/S (NTM)

2.17x

Rev growth (TTM)

59.6%

YTD performance

-13.4%

52W performance

-42.2%

FCF yield

-3.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACAD

LEGN

Detailed metrics comparison

ACAD

ACADIA Pharmaceuticals Inc

LEGN

Legend Biotech Corp

Market Cap

ACAD$3.39B

LEGN$3.62B

Enterprise Value

ACAD$3.00B

LEGN$3.23B

Price

ACAD$19.78

LEGN$18.62

P/E Ratio

ACAD8.99x

LEGNN/A

P/S Ratio

ACAD2.97x

LEGN2.85x

EV/Sales

ACAD2.64x

LEGN2.54x

EV/EBITDA

ACAD24.70x

LEGN0.00x

P/B Ratio

ACAD2.63x

LEGN3.04x

P/FCF Ratio

ACAD23.26x

LEGNN/A

EV/FCF

ACAD20.62x

LEGN-26.50x

PEG Ratio

ACAD0.13x

LEGNN/A

Forward P/E (NTM)

ACAD23.42x

LEGN25.42x

Forward P/S (NTM)

ACAD2.37x

LEGN2.17x

Revenue (TTM)

ACAD$1.14B

LEGN$1.27B

Revenue Growth (YoY)

ACAD48.3%

LEGN59.6%

Forward Rev Growth

ACAD12.6%

LEGN25.0%

Gross Margin (TTM)

ACAD91.1%

LEGN56.6%

Operating Margin (TTM)

ACAD7.6%

LEGN0.0%

EBITDA Margin (TTM)

ACAD8.6%

LEGN-0.8%

Net Margin (TTM)

ACAD33.4%

LEGN-7.2%

FCF Margin (TTM)

ACAD12.8%

LEGN-9.6%

Net Income (TTM)

ACAD$380M

LEGN$-92M

FCF (TTM)

ACAD$146M

LEGN$-122M

EPS (TTM)

ACAD$2.20

LEGN-$0.47

ROE (TTM)

ACAD32.4%

LEGN-870.0%

ROA (TTM)

ACAD24.4%

LEGN-539.0%

ROIC (TTM)

ACAD32.4%

LEGN-643.0%

Cash

ACAD$385M

LEGN$673M

Debt

ACAD$0

LEGN$278M

Net Cash/Debt

ACAD$385M

LEGN$395M

Current Ratio (TTM)

ACAD3.39x

LEGN3.04x

Quick Ratio (TTM)

ACAD3.11x

LEGN2.89x

Debt/Equity (TTM)

ACAD0.00x

LEGN0.23x

Debt/Assets (TTM)

ACAD0.0%

LEGN0.0%

Interest Coverage (TTM)

ACADN/A

LEGNN/A

Net Debt/EBITDA (TTM)

ACAD0.00x

LEGN0.00x

Beta

ACAD0.91

LEGN0.57

52W Performance

ACAD-7.2%

LEGN-42.2%

YTD Performance

ACAD-24.8%

LEGN-13.4%

% from 52W High

ACAD-36.1%

LEGN-50.3%

% from 52W Low

ACAD2.4%

LEGN14.7%

Asset Turnover (TTM)

ACAD0.73x

LEGN0.75x

FCF Yield (TTM)

ACAD4.3%

LEGN-3.4%

Earnings Yield (TTM)

ACAD11.2%

LEGN-2.5%

Dividend Yield (TTM)

ACADN/A

LEGNN/A

Rule of 40

ACAD61.1

LEGN50.0

EV/GP/RG

ACAD0.09

LEGN0.13

Ticker research

View ACAD research View LEGN research

Metric	ACAD ACADIA Pharmaceuticals Inc	LEGN Legend Biotech Corp
Market & Valuation
Market Cap	$3.39B	$3.62B
Enterprise Value	$3.00B	$3.23B
Price	$19.78	$18.62
P/E Ratio	8.99x	N/A
P/S Ratio	2.97x	2.85x
EV/Sales	2.64x	2.54x
EV/EBITDA	24.70x	0.00x
P/B Ratio	2.63x	3.04x
P/FCF Ratio	23.26x	N/A
EV/FCF	20.62x	-26.50x
PEG Ratio	0.13x	N/A
Forward P/E (NTM)	23.42x	25.42x
Forward P/S (NTM)	2.37x	2.17x
Revenue & Growth
Revenue (TTM)	$1.14B	$1.27B
Revenue Growth (YoY)	48.3%	59.6%
Forward Rev Growth	12.6%	25.0%
Profitability
Gross Margin (TTM)	91.1%	56.6%
Operating Margin (TTM)	7.6%	0.0%
EBITDA Margin (TTM)	8.6%	-0.8%
Net Margin (TTM)	33.4%	-7.2%
FCF Margin (TTM)	12.8%	-9.6%
Net Income (TTM)	$380M	$-92M
FCF (TTM)	$146M	$-122M
EPS (TTM)	$2.20	-$0.47
ROE (TTM)	32.4%	-870.0%
ROA (TTM)	24.4%	-539.0%
ROIC (TTM)	32.4%	-643.0%
Financial Health
Cash	$385M	$673M
Debt	$0	$278M
Net Cash/Debt	$385M	$395M
Current Ratio (TTM)	3.39x	3.04x
Quick Ratio (TTM)	3.11x	2.89x
Debt/Equity (TTM)	0.00x	0.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.91	0.57
52W Performance	-7.2%	-42.2%
YTD Performance	-24.8%	-13.4%
% from 52W High	-36.1%	-50.3%
% from 52W Low	2.4%	14.7%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.75x
FCF Yield (TTM)	4.3%	-3.4%
Earnings Yield (TTM)	11.2%	-2.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	61.1	50.0
EV/GP/RG	0.09	0.13
Ticker research	View ACAD research	View LEGN research

Valuation

P/E Ratio

ACAD

8.99x

P/S Ratio

LEGN

2.85x

ACAD

2.97x

EV/FCF

LEGN

-26.50x

ACAD

20.62x

Growth & revenue

Revenue Growth TTM

LEGN

59.6%

ACAD

48.3%

Forward Revenue Growth

LEGN

25.0%

ACAD

12.6%

Profitability & performance

Gross Margin

ACAD

91.1%

LEGN

56.6%

ROE

ACAD

32.4%

LEGN

-870.0%

FCF Yield %

ACAD

4.3%

LEGN

-3.4%

52-Week Performance

ACAD

-7.2%

LEGN

-42.2%

Detailed metrics comparison

ACAD

ACADIA Pharmaceuticals Inc

LEGN

Legend Biotech Corp

Market Cap

ACAD$3.39B

LEGN$3.62B

Enterprise Value

ACAD$3.00B

LEGN$3.23B

Price

ACAD$19.78

LEGN$18.62

P/E Ratio

ACAD8.99x

LEGNN/A

P/S Ratio

ACAD2.97x

LEGN2.85x

EV/Sales

ACAD2.64x

LEGN2.54x

EV/EBITDA

ACAD24.70x

LEGN0.00x

P/B Ratio

ACAD2.63x

LEGN3.04x

P/FCF Ratio

ACAD23.26x

LEGNN/A

EV/FCF

ACAD20.62x

LEGN-26.50x

PEG Ratio

ACAD0.13x

LEGNN/A

Forward P/E (NTM)

ACAD23.42x

LEGN25.42x

Forward P/S (NTM)

ACAD2.37x

LEGN2.17x

Revenue (TTM)

ACAD$1.14B

LEGN$1.27B

Revenue Growth (YoY)

ACAD48.3%

LEGN59.6%

Forward Rev Growth

ACAD12.6%

LEGN25.0%

Gross Margin (TTM)

ACAD91.1%

LEGN56.6%

Operating Margin (TTM)

ACAD7.6%

LEGN0.0%

EBITDA Margin (TTM)

ACAD8.6%

LEGN-0.8%

Net Margin (TTM)

ACAD33.4%

LEGN-7.2%

FCF Margin (TTM)

ACAD12.8%

LEGN-9.6%

Net Income (TTM)

ACAD$380M

LEGN$-92M

FCF (TTM)

ACAD$146M

LEGN$-122M

EPS (TTM)

ACAD$2.20

LEGN-$0.47

ROE (TTM)

ACAD32.4%

LEGN-870.0%

ROA (TTM)

ACAD24.4%

LEGN-539.0%

ROIC (TTM)

ACAD32.4%

LEGN-643.0%

Cash

ACAD$385M

LEGN$673M

Debt

ACAD$0

LEGN$278M

Net Cash/Debt

ACAD$385M

LEGN$395M

Current Ratio (TTM)

ACAD3.39x

LEGN3.04x

Quick Ratio (TTM)

ACAD3.11x

LEGN2.89x

Debt/Equity (TTM)

ACAD0.00x

LEGN0.23x

Debt/Assets (TTM)

ACAD0.0%

LEGN0.0%

Interest Coverage (TTM)

ACADN/A

LEGNN/A

Net Debt/EBITDA (TTM)

ACAD0.00x

LEGN0.00x

Beta

ACAD0.91

LEGN0.57

52W Performance

ACAD-7.2%

LEGN-42.2%

YTD Performance

ACAD-24.8%

LEGN-13.4%

% from 52W High

ACAD-36.1%

LEGN-50.3%

% from 52W Low

ACAD2.4%

LEGN14.7%

Asset Turnover (TTM)

ACAD0.73x

LEGN0.75x

FCF Yield (TTM)

ACAD4.3%

LEGN-3.4%

Earnings Yield (TTM)

ACAD11.2%

LEGN-2.5%

Dividend Yield (TTM)

ACADN/A

LEGNN/A

Rule of 40

ACAD61.1

LEGN50.0

EV/GP/RG

ACAD0.09

LEGN0.13

Ticker research

View ACAD research View LEGN research

Metric	ACAD ACADIA Pharmaceuticals Inc	LEGN Legend Biotech Corp
Market & Valuation
Market Cap	$3.39B	$3.62B
Enterprise Value	$3.00B	$3.23B
Price	$19.78	$18.62
P/E Ratio	8.99x	N/A
P/S Ratio	2.97x	2.85x
EV/Sales	2.64x	2.54x
EV/EBITDA	24.70x	0.00x
P/B Ratio	2.63x	3.04x
P/FCF Ratio	23.26x	N/A
EV/FCF	20.62x	-26.50x
PEG Ratio	0.13x	N/A
Forward P/E (NTM)	23.42x	25.42x
Forward P/S (NTM)	2.37x	2.17x
Revenue & Growth
Revenue (TTM)	$1.14B	$1.27B
Revenue Growth (YoY)	48.3%	59.6%
Forward Rev Growth	12.6%	25.0%
Profitability
Gross Margin (TTM)	91.1%	56.6%
Operating Margin (TTM)	7.6%	0.0%
EBITDA Margin (TTM)	8.6%	-0.8%
Net Margin (TTM)	33.4%	-7.2%
FCF Margin (TTM)	12.8%	-9.6%
Net Income (TTM)	$380M	$-92M
FCF (TTM)	$146M	$-122M
EPS (TTM)	$2.20	-$0.47
ROE (TTM)	32.4%	-870.0%
ROA (TTM)	24.4%	-539.0%
ROIC (TTM)	32.4%	-643.0%
Financial Health
Cash	$385M	$673M
Debt	$0	$278M
Net Cash/Debt	$385M	$395M
Current Ratio (TTM)	3.39x	3.04x
Quick Ratio (TTM)	3.11x	2.89x
Debt/Equity (TTM)	0.00x	0.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.91	0.57
52W Performance	-7.2%	-42.2%
YTD Performance	-24.8%	-13.4%
% from 52W High	-36.1%	-50.3%
% from 52W Low	2.4%	14.7%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.75x
FCF Yield (TTM)	4.3%	-3.4%
Earnings Yield (TTM)	11.2%	-2.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	61.1	50.0
EV/GP/RG	0.09	0.13
Ticker research	View ACAD research	View LEGN research